Clinical Trials Browser

INDUSTRY × GSK 1363089 × Gastrointestinal × Clear all

NCT00725712 2017-08-24

Study of GSK1363089 in Metastatic Gastric Cancer

Phase 2 Completed

74 enrolled 22 charts

Gastrointestinal

Adenocarcinoma, Neoplasms, Stomach Neoplasms

NCT00920192 2017-07-18

Safety Study of Foretinib (GSK1363089) in Adults With Liver Cancer

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular